Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -18,320 | -11,150 | -5,537 | -13,658 |
| Depreciation Amortization | 834 | 488 | 222 | 519 |
| Accounts payable and accrued liabilities | 1,071 | 505 | 469 | N/A |
| Other Working Capital | 21,448 | 20,542 | 75 | 299 |
| Other Operating Activity | -706 | -269 | -358 | 318 |
| Operating Cash Flow | $4,327 | $10,116 | $-5,129 | $-12,522 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,853 | -1,510 | -1,187 | -1,247 |
| Investing Cash Flow | $-2,853 | $-1,510 | $-1,187 | $-1,247 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 248 | 247 | 221 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 34,812 |
| Financing Cash Flow | $248 | $247 | $221 | $34,812 |
| Beginning Cash Position | 42,359 | 42,359 | 42,359 | 21,316 |
| End Cash Position | 44,081 | 51,212 | 36,264 | 42,359 |
| Net Cash Flow | $1,722 | $8,853 | $-6,095 | $21,043 |
| Free Cash Flow | ||||
| Operating Cash Flow | 4,327 | 10,116 | -5,129 | -12,522 |
| Capital Expenditure | -2,853 | -1,510 | -1,187 | N/A |
| Free Cash Flow | 1,474 | 8,606 | -6,316 | -12,522 |